Literature DB >> 3713262

Breast reconstruction: current state of the art.

J E Woods.   

Abstract

The current state of the art makes breast reconstruction possible in any patient who has undergone mastectomy, whether simple, modified radical, or radical. Indications for reconstruction are a strong desire on the part of the patient and a reasonable life expectancy. Methods of reconstruction include the simple placement of a breast prosthesis alone (submuscularly when possible) or in combination with advancement of upper abdominal skin or rotation flaps. Expander implants are useful in patients with limited skin and musculature. For the patient with serious muscle and skin deficits, more complex reconstructive procedures with use of transverse rectus abdominis or latissimus dorsi myocutaneous flaps may be performed, with or without an implant. Several methods of reconstruction of the nipple and areola are also possible. Treatment of the opposite breast is often necessary if symmetry is to be achieved. When appropriate, augmentation, mastopexy, reduction, or subcutaneous mastectomy may be performed. There is no single preferred method of reconstruction. The approach should be tailored for each patient.

Entities:  

Mesh:

Year:  1986        PMID: 3713262     DOI: 10.1016/s0025-6196(12)62008-4

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  3 in total

Review 1.  Hereditary breast and ovarian cancer: review and future perspectives.

Authors:  Michael P Lux; Peter A Fasching; Matthias W Beckmann
Journal:  J Mol Med (Berl)       Date:  2005-11-11       Impact factor: 4.599

Review 2.  [Prophylactic surgery of mammary and ovarian carcinoma].

Authors:  M P Lux; M R Bani; P A Fasching; M W Beckmann
Journal:  Chirurg       Date:  2005-12       Impact factor: 0.955

3.  Importance of revealing a rare case of breast cancer in a female to male transsexual after bilateral mastectomy.

Authors:  Dejan V Nikolic; Miroslav L Djordjevic; Miroslav Granic; Aleksandra T Nikolic; Violeta V Stanimirovic; Darko Zdravkovic; Svetlana Jelic
Journal:  World J Surg Oncol       Date:  2012-12-28       Impact factor: 2.754

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.